"10.1371_journal.ppat.1000703","plos pathogens","2009-12-24T00:00:00Z","Lin Lin; Ashraf S Ibrahim; Xin Xu; Joshua M Farber; Valentina Avanesian; Beverlie Baquir; Yue Fu; Samuel W French; John E Edwards; Brad Spellberg","The Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance, California, United States of America; The David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; The Department of Pathology, Harbor-UCLA Medical Center, Torrance, California, United States of America; The Division of General Internal Medicine, Harbor-UCLA Medical Center, Torrance, California, United States of America","Conceived and designed the experiments: LL ASI JMF BS. Performed the experiments: LL ASI XX VA BB YF BS. Analyzed the data: LL SWF BS. Contributed reagents/materials/analysis tools: XX JMF VA YF JEEJ BS. Wrote the paper: LL BS.","BS, ASI, YF, and JEE own equity in NovaDigm Therapeutics, Inc., which is developing vaccine technologies. NovaDigm Therapeutics, Inc. provided no financial support for these studies.","2009","12","Lin Lin","LL",10,TRUE,4,7,3,2,TRUE,TRUE,TRUE,1,"9",FALSE
